My Companies
Notification
Account
Log Out
Back

Asston Pharmaceuticals Board Approves ₹27.7 Crore Preferential Issue To Non-Promoters

2 July 2026
Asston Pharmaceuticals Ltd.

Board approved preferential issue of up to 24.10 lakh equity shares at Rs 115 per share aggregating ~27.7 Cr to non-promoter allottees, subject to shareholder approval. EGM set for 31 July 2026.

Recent Events

5 September 2026

Asston Pharmaceuticals Allots 24.1 Lakh Shares Under ₹27.72 Crore Preferential Issue
4 September 2026

Asston Pharmaceuticals' Prakruti R Pali Raises Stake To 9.03%
2 September 2026

Asston Pharmaceuticals' Prakruti Pali Raises Open-Market Stake To 7.26%

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information